NCT05378555View on ClinicalTrials.gov

Oral Ketamine for Treatment of Vaso-Occlusive Pain

PHASE3RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 1, 2026

Conditions
Vaso-occlusive Crisis
Interventions
DRUG

Ketamine Hydrochloride

All patients in this study will receive oral ketamine for the treatment of pain from vaso-occlusive crisis. Patients will receive 0.5 mg/kg ketamine Q8hrs for 48 hours.

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER